XML 44 R34.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Net Income Attributable to IPG Photonics Corporation Per Common Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Earnings Per Share [Abstract] |
Computation of Diluted Net Income Per Share | The following table sets forth the computation of diluted net income attributable to IPG Photonics Corporation per common share following the treasury stock method:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Net income attributable to IPG Photonics Corporation common stockholders | $ | 76,264 |  |  | $ | 75,402 |  |  | $ | 202,804 |  |  | $ | 213,329 |
Basic weighted average common shares | 51,628,701 |  |  | 53,387,175 |  |  | 51,449,367 |  |  | 53,500,507 |
Dilutive effect of common stock equivalents | 108,289 |  |  | 446,577 |  |  | 176,565 |  |  | 552,836 |
Diluted weighted average common shares | 51,736,990 |  |  | 53,833,752 |  |  | 51,625,932 |  |  | 54,053,343 |
Basic net income attributable to IPG Photonics Corporation per common share | $ | 1.48 |  |  | $ | 1.41 |  |  | $ | 3.94 |  |  | $ | 3.99 |
Diluted net income attributable to IPG Photonics Corporation per common share | $ | 1.47 |  |  | $ | 1.40 |  |  | $ | 3.93 |  |  | $ | 3.95 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The weighted average anti-dilutive shares outstanding for the three and nine months ended September 30, 2022 and 2021 were as follows:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Non-qualified stock options | 672,539 |  |  | 225,684 |  |  | 604,394 |  |  | 202,077 |
Restricted stock units | 373,646 |  |  | 128,402 |  |  | 340,924 |  |  | 100,066 |
Performance stock units | 91,920 |  |  | 30,142 |  |  | 78,999 |  |  | 24,732 |
Total weighed average anti-dilutive shares outstanding | 1,138,105 |  |  | 384,228 |  |  | 1,024,317 |  |  | 326,875 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration